Cargando…
Treatment of Experimental Autoimmune Encephalomyelitis with an Inhibitor of Phosphodiesterase-8 (PDE8)
After decades of development, inhibitors targeting cyclic nucleotide phosphodiesterases (PDEs) expressed in leukocytes have entered clinical practice for the treatment of inflammatory disorders, with three PDE4 inhibitors being in clinical use as therapeutics for psoriasis, psoriatic arthritis, chro...
Autores principales: | Basole, Chaitali P., Nguyen, Rebecca K., Lamothe, Katie, Billis, Puja, Fujiwara, Mai, Vang, Amanda G., Clark, Robert B., Epstein, Paul M., Brocke, Stefan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870644/ https://www.ncbi.nlm.nih.gov/pubmed/35203312 http://dx.doi.org/10.3390/cells11040660 |
Ejemplares similares
-
The Role of PDE8 in T Cell Recruitment and Function in Inflammation
por: Epstein, Paul M., et al.
Publicado: (2021) -
Differential Expression and Function of PDE8 and PDE4 in Effector T cells: Implications for PDE8 as a Drug Target in Inflammation
por: Vang, Amanda G., et al.
Publicado: (2016) -
Expression of phosphodiesterase 6 (PDE6) in human breast cancer cells
por: Dong, Hongli, et al.
Publicado: (2013) -
PDE8 Regulates Rapid Teff Cell Adhesion and Proliferation Independent of ICER
por: Vang, Amanda G., et al.
Publicado: (2010) -
TLR8: the forgotten relative revindicated
por: Cervantes, Jorge L, et al.
Publicado: (2012)